The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

LPL gene Pvu II polymorphism and hypertriglyceridemia: a meta-analysis involving 1,640 subjects

  • Li, Yan-yan (Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University) ;
  • Zhou, Yan-hong (Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University) ;
  • Gong, Ge (Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University) ;
  • Geng, Hong-yu (Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University) ;
  • Yang, Xin-xing (Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University) ;
  • Wang, Xiang-ming (Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University) ;
  • Zhou, Chuan-wei (Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University) ;
  • Xu, Jian (Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University) ;
  • Qian, Yun (Department of Geriatrics, First Affiliated Hospital of Nanjing Medical University)
  • Received : 2016.02.15
  • Accepted : 2016.06.15
  • Published : 2017.11.01
⟨ Previous Next ⟩

Abstract

Background/Aims: Although lipoprotein lipase (LPL) gene Pvu II polymorphism has been associated with an increased risk of hypertriglyceridemia (HT), there is no clear consensus within the scientific community. Methods: A meta-analysis of 1,640 subjects from six individual studies was conducted to better elucidate the potential relationship between the LPL gene Pvu II polymorphism and HT within the Chinese population. Pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) were evaluated by using fixed effect models. Results: Our analysis indicated a significant association between LPL gene Pvu II polymorphism and HT within the Chinese population under allelic (OR, 1.550; 95% CI, 1.320 to 1.830; $p=1.158{\times}10^{-7}$), recessive (OR, 0.540; 95% CI, 0.390 to 0.750; p = 0.0002), dominant (OR, 1.889; 95% CI, 1.501 to 2.377; $p=5.960{\times}10^{-8}$), homozygous (OR, 2.167; 95% CI, 1.531 to 3.067; $p=1.242{\times}10^{-5}$), heterozygous (OR, 1.810; 95% CI, 1.419 to 2.309; $p=1.842{\times}10^{-6}$), and additive genetic models (OR, 1.553; 95% CI, 1.320 to 1.828; $p=1.158{\times}10^{-7}$). Conclusions: Because LPL gene Pvu II restriction fragment length polymorphism polymorphism was associated with an elevated risk of HT, the P+ allele carriers of the LPL gene might be predisposed to HT.

Keywords

Acknowledgement

Supported by : National Natural Science Foundation of China, Nanjing Medical University

References

  1. Stancakova A, Baldaufova L, Javorsky M, Kozarova M, Salagovic J, Tkac I. Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome. Physiol Res 2006;55:483-490.
  2. Helgadottir A, Gretarsdottir S, Thorleifsson G, et al. Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease. Nat Genet 2016;48:634-639. https://doi.org/10.1038/ng.3561
  3. Gui L, Jia C, Zhang Y, Zhao C, Zan L. Association studies on the bovine lipoprotein lipase gene polymorphism with growth and carcass quality traits in Qinchuan cattle. Mol Cell Probes 2016;30:61-65. https://doi.org/10.1016/j.mcp.2016.01.006
  4. Du JK, Huang QY. Research progress of lipoprotein lipase gene. Yi Chuan 2007;29:8-16. https://doi.org/10.1360/yc-007-0008
  5. Fan Y, Zhang R, Liu B, Zhang Z. Studies on association between lipoprotein lipase gene polymorphisms of Pvu II site and hypertriglyceridemics in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2001;18:296-298.
  6. Wang K, Ao YT, Wu GZ, et al. The relationship between LPL, CETP gene polymorphism and hyperlipidemia in Xinjiang Kazaka people. Chin J Med Guide 2006;8:255-258.
  7. Huang L, Guo HW, Huang ZY, Xue K. The association of lipoprotein lipase gene polymorphism with hyperlipidemia and dietary predisposition of obesity. Ying Yang Xue Bao 2007;29:228-231.
  8. Cochran WG. The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics 1968;24:295-313. https://doi.org/10.2307/2528036
  9. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
  10. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634. https://doi.org/10.1136/bmj.315.7109.629
  11. Zhu WL, Qi Z, Zhang ZT, Xiao Y. The study on the relationship between lipoprotein lipase gene polymorphism and hyperlipidemia in the middle-aged and aged people of Xicheng District of Beijing City. Chin J Med Genet 2002;19(Suppl):361-362.
  12. Liu J, Zhu TH. The associations of lipoprotein lipase gene Pvu II RFLP with plasma lipids and coronary heart disease [master's thesis]. Tianjin (CH): Medical College of Nankai University, 1999.
  13. Zhu TB, Wang Q. Relationship between lipoprotein lipase gene polymorphism and hypertriglyceridemia. Acta Univ Med Nanjing 1998;18:297-298.
  14. Cui XD, Zhang XY, Jiang MN, Song LX, Ge GY, Jia YJ. DNA polymorphism of Pvu II sites in the lipoprotein lipase gene in patients with hyper lipoidemia. Jiangxi Med J 2008;43:16-19.
  15. Zhu XM, Xu X, Chen SQ. Correlation of lipoprotein lipase gene polymorphism at Pvu II locus and plasm lipids of elderly population. Acad J Guangzhou Med Coll 2005;33:17-20.
  16. Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992;97:171-185. https://doi.org/10.1016/0021-9150(92)90130-9
  17. Hayden MR, Liu MS, Ma Y. Gene environment interaction and plasma triglyceride levels: the crucial role of lipoprotein lipase. Clin Genet 1994;46:15-18.
  18. Ukkola O, Tremblay A, Bouchard C. Lipoprotein lipase polymorphisms and responses to long-term overfeeding. J Intern Med 2002;251:429-436. https://doi.org/10.1046/j.1365-2796.2002.00981.x
  19. Nicklas BJ, Ferrell RE, Rogus EM, et al. Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women. Hum Genet 2000;106:420-424. https://doi.org/10.1007/s004390000292
  20. Cui LL, Wang M, Huang QY. Meta-analysis of LPL Pvu II polymorphism with hyperlipoidemia and coronary heart disease in the Chinese population. Yi Chuan 2010;32:1031-1036.
  21. Quteineh L, Bochud PY, Golshayan D, et al. CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation. Pharmacogenomics J 2017;17:69-75. https://doi.org/10.1038/tpj.2015.82
  22. Hsiao PJ, Lee MY, Wang YT, et al. MTTP-297H polymorphism reduced serum cholesterol but increased risk of non-alcoholic fatty liver disease-a cross-sectional study. BMC Med Genet 2015;16:93.